Food and Drug Administration (FDA)

• HDMA Testimony at Joint FDA Advisory Committee Meeting on iPLEDGE - August 1, 2007
• HDMA Written Comments on Risk Minimization Action Plans (RiskMAPs) - July 27, 2007
• Distributors' Perspective on the Implementation of Risk Minimization Action Plans (RiskMAPs) - June 25, 2007
• HDMA Written Comments on Electronic Prescribing Information - June 22, 2007
• HDMA Testifies at FDA's MedGuide Hearing 6-13-07 - June 18, 2007
• HDMA Testifies on Electronic Prescribing Information Distribution - April 27, 2007
• Agenda for the FDA Public Hearing on Electronic Prescribing Information - April 27, 2007
• HDMA Comments on the Proposed NDC Rule - January 26, 2007
• HDMA Testimony on FDA's Proposed NDC Rule - December 11, 2006
• Patient Safety Implications on Implementation of the Current FDA-Mandated Medication Guide Program - June 27, 2006

Centers for Medicare and Medicaid Services (CMS)

• HDMA Policy Position on Congressional Proposals to Preserve Community Pharmacies, Patient Access to Care and Appropriate Use of Generic Medicines Under the Medicaid Program - October 1, 2007
• HDMA Statement on CMS’s Final Rule on AMP - July 17, 2007
• HDMA Public Comments on the Proposed AMP Rule - February 20, 2007

Department of Defense (DoD)

• HDMA Comment Letter to DoD on DFARS Rule - July 18, 2006
  
  

Contacts
Anita Ducca
Senior Director, Regulatory Affairs and Healthcare Policy
703-885-0240
aducca@hdmanet.org

Brian Cherico
Manager, Regulatory Affairs and Healthcare Policy
703-885-0257
bcherico@hdmanet.org